A framework for joint assessment of a terminal event and a score existing only in the absence of the terminal event
终末事件与仅在事件未发生时存在的评分之联合评估框架
Analysis of data from randomized controlled trials in vulnerable populations requires special attention when assessing treatment effect by a score measuring, e.g., disease stage or activity together with onset of prevalent terminal events. In reality, it is impossible to disentangle a disease score from the terminal event, since the score is not clinically meaningful after this event. In this work, we propose to assess treatment interventions simultaneously on the terminal…